327 related articles for article (PubMed ID: 26934555)
21. A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma.
Indolfi L; Ligorio M; Ting DT; Xega K; Tzafriri AR; Bersani F; Aceto N; Thapar V; Fuchs BC; Deshpande V; Baker AB; Ferrone CR; Haber DA; Langer R; Clark JW; Edelman ER
Biomaterials; 2016 Jul; 93():71-82. PubMed ID: 27082874
[TBL] [Abstract][Full Text] [Related]
22. Establishment of a Liver Transplant Patient-derived Tumor Xenograft (PDX) Model Using Cryopreserved Pancreatic Ductal Adenocarcinoma.
Tanaka R; Kageyama K; Kimura K; Eguchi S; Tauchi J; Shinkawa H; Ohira GO; Yamazoe S; Yamamoto A; Tanaka S; Amano R; Tanaka H; Yashiro M; Kubo S; Ohira M
Anticancer Res; 2020 May; 40(5):2637-2644. PubMed ID: 32366408
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
[TBL] [Abstract][Full Text] [Related]
24. Surgical and Oncological Factors Affecting the Successful Engraftment of Patient-derived Xenografts in Pancreatic Ductal Adenocarcinoma.
Jun E; Jung J; Jeong SY; Choi EK; Kim MB; Lee JS; Hong SM; Seol HS; Hwang C; Hoffman RM; Shim IK; Chang S; Kim SC
Anticancer Res; 2016 Feb; 36(2):517-21. PubMed ID: 26851005
[TBL] [Abstract][Full Text] [Related]
25. Mouse Models of Pancreatic Ductal Adenocarcinoma.
Ponz-Sarvise M; Tuveson DA; Yu KH
Hematol Oncol Clin North Am; 2015 Aug; 29(4):609-17. PubMed ID: 26226900
[TBL] [Abstract][Full Text] [Related]
26. Establishment and Characterisation by Expression Microarray of Patient-Derived Xenograft Panel of Human Pancreatic Adenocarcinoma Patients.
Roche S; O'Neill F; Murphy J; Swan N; Meiller J; Conlon NT; Geoghegan J; Conlon K; McDermott R; Rahman R; Toomey S; Straubinger NL; Straubinger RM; O'Connor R; McVey G; Moriarty M; Clynes M
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32024004
[TBL] [Abstract][Full Text] [Related]
27. Development of Patient-Derived Tumor Xenograft Models.
Annibali D; Leucci E; Hermans E; Amant F
Methods Mol Biol; 2019; 1862():217-225. PubMed ID: 30315470
[TBL] [Abstract][Full Text] [Related]
28. Detection of KRAS gene mutations in endoscopic ultrasound-guided fine-needle aspiration biopsy for improving pancreatic cancer diagnosis.
Wang X; Gao J; Ren Y; Gu J; Du Y; Chen J; Jin Z; Zhan X; Li Z; Huang H; Lv S; Gong Y
Am J Gastroenterol; 2011 Dec; 106(12):2104-11. PubMed ID: 21876563
[TBL] [Abstract][Full Text] [Related]
29. IQGAP1 Maintains Pancreatic Ductal Adenocarcinoma Clonogenic Growth and Metastasis.
Li JH; McMillan RH; Begum A; Gocke CB; Matsui W
Pancreas; 2019 Jan; 48(1):94-98. PubMed ID: 30540680
[TBL] [Abstract][Full Text] [Related]
30. Endoscopic Ultrasound-Guided Fine-Needle Biopsies to Generate Preclinical Disease Models to Study Inflammation in Pancreatic Ductal Adenocarcinoma.
Lundy J; Croagh D
Methods Mol Biol; 2023; 2691():43-54. PubMed ID: 37355536
[TBL] [Abstract][Full Text] [Related]
31. CXCR2 signaling regulates KRAS(G¹²D)-induced autocrine growth of pancreatic cancer.
Purohit A; Varney M; Rachagani S; Ouellette MM; Batra SK; Singh RK
Oncotarget; 2016 Feb; 7(6):7280-96. PubMed ID: 26771140
[TBL] [Abstract][Full Text] [Related]
32. Personalized RNA Medicine for Pancreatic Cancer.
Gilles ME; Hao L; Huang L; Rupaimoole R; Lopez-Casas PP; Pulver E; Jeong JC; Muthuswamy SK; Hidalgo M; Bhatia SN; Slack FJ
Clin Cancer Res; 2018 Apr; 24(7):1734-1747. PubMed ID: 29330203
[No Abstract] [Full Text] [Related]
33. A fast, simple, and cost-effective method of expanding patient-derived xenograft mouse models of pancreatic ductal adenocarcinoma.
Liu Z; Ahn MH; Kurokawa T; Ly A; Zhang G; Wang F; Yamada T; Sadagopan A; Cheng J; Ferrone CR; Liss AS; Honselmann KC; Wojtkiewicz GR; Ferrone S; Wang X
J Transl Med; 2020 Jun; 18(1):255. PubMed ID: 32580742
[TBL] [Abstract][Full Text] [Related]
34. A MEK/PI3K/HDAC inhibitor combination therapy for KRAS mutant pancreatic cancer cells.
Ischenko I; Petrenko O; Hayman MJ
Oncotarget; 2015 Jun; 6(18):15814-27. PubMed ID: 26158412
[TBL] [Abstract][Full Text] [Related]
35. Prometastatic secretome trafficking via exosomes initiates pancreatic cancer pulmonary metastasis.
Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
Cancer Lett; 2020 Jul; 481():63-75. PubMed ID: 32145343
[TBL] [Abstract][Full Text] [Related]
36. Integrated Patient-Derived Models Delineate Individualized Therapeutic Vulnerabilities of Pancreatic Cancer.
Witkiewicz AK; Balaji U; Eslinger C; McMillan E; Conway W; Posner B; Mills GB; O'Reilly EM; Knudsen ES
Cell Rep; 2016 Aug; 16(7):2017-31. PubMed ID: 27498862
[TBL] [Abstract][Full Text] [Related]
37. Pretest prediction and diagnosis of metastatic lesions to the pancreas by endoscopic ultrasound-guided fine needle aspiration.
Krishna SG; Bhattacharya A; Ross WA; Ladha H; Porter K; Bhutani MS; Lee JH
J Gastroenterol Hepatol; 2015 Oct; 30(10):1552-60. PubMed ID: 25867963
[TBL] [Abstract][Full Text] [Related]
38. A subgroup of pancreatic adenocarcinoma is sensitive to the 5-aza-dC DNA methyltransferase inhibitor.
Gayet O; Loncle C; Duconseil P; Gilabert M; Lopez MB; Moutardier V; Turrini O; Calvo E; Ewald J; Giovannini M; Gasmi M; Bories E; Barthet M; Ouaissi M; Goncalves A; Poizat F; Raoul JL; Secq V; Garcia S; Viens P; Dusetti N; Iovanna J
Oncotarget; 2015 Jan; 6(2):746-54. PubMed ID: 25481873
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of geranylgeranyl diphosphate synthase is a novel therapeutic strategy for pancreatic ductal adenocarcinoma.
Haney SL; Varney ML; Chhonker YS; Shin S; Mehla K; Crawford AJ; Smith HJ; Smith LM; Murry DJ; Hollingsworth MA; Holstein SA
Oncogene; 2019 Jun; 38(26):5308-5320. PubMed ID: 30918331
[TBL] [Abstract][Full Text] [Related]
40. Epicatechin-rich cocoa polyphenol inhibits Kras-activated pancreatic ductal carcinoma cell growth in vitro and in a mouse model.
Siddique HR; Liao DJ; Mishra SK; Schuster T; Wang L; Matter B; Campbell PM; Villalta P; Nanda S; Deng Y; Saleem M
Int J Cancer; 2012 Oct; 131(7):1720-31. PubMed ID: 22190076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
